Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nicola Eaddy"'
Publikováno v:
Internal Medicine Journal. 52:491-494
Spontaneous venous thromboembolism (VTE) may represent the first manifestation of previously undiagnosed malignancy; however, contemporary international guidelines call for a limited approach to screening for malignancy in such patients. This retrosp
Publikováno v:
Internal Medicine Journal.
Rivaroxaban is used increasingly as an oral anticoagulant; however, a specific reversal agent is not currently available in the Australasian setting. There is also variation across international consensus guidelines regarding advice on the management
Autor:
George Chan, Nicole Chien, Peter Browett, Nicola Eaddy, Tim E. Hawkins, Edward Theakston, Richard Doocey, Taryn N. Green, Leanne Berkahn, Chris Varghese, Maggie L. Kalev-Zylinska
Publikováno v:
Leukemia research. 93
All-trans retinoic acid (ATRA) and arsenic trioxide (ATO) are effective induction therapy for acute promyelocytic leukaemia (APL). However, early thrombo-haemorrhagic complications and mortality remain high. We aimed to investigate how the timing of
Publikováno v:
Clinical Kidney Journal. 14:710-711
Anticoagulant-related nephropathy (ARN) is a clinical syndrome of acute kidney injury in patients taking vitamin K antagonists or direct oral anticoagulants. It is associated with increased mortality and there is no specific treatment. We report the
Publikováno v:
American journal of hematology. 93(1)
Publikováno v:
Nephrology. 18:580-582
Publikováno v:
Pathology. 44:578-580
Autor:
Paul Oei, Nicola Eaddy, Peter Browett, Edward Chew, Lynda J. Campbell, Jake Shortt, Ross Brookwell, Ashley P. Ng
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2013 (2013)
BioMed Research International, Vol 2013 (2013)
The diagnosis of acute promyelocytic leukaemia (APL) is usually confirmed by cytogenetics showing the characteristic t(15;17), but a minority of patients have a maskedPML/RARAfusion. We report ten patients with APL and no evidence of the t(15;17), in